Raymond James Financial
MIRM icon

Raymond James Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

Raymond James Financial’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
233,311
+5,137
+2% +$516K 0.01% 1341
2026
Q1 		$21.1M Sell
228,174
-18,244
-7% -$1.72M 0.01% 1434
2025
Q4 		$19.5M Sell
246,418
-5,315
-2% -$381K 0.01% 1457
2025
Q3 		$18.5M Sell
251,733
-12,385
-5% -$787K 0.01% 1468
2025
Q2 		$13.4M Buy
264,118
+14,800
+6% +$659K ﹤0.01% 1651
2025
Q1 		$11.2M Sell
249,318
-7,294
-3% -$344K ﹤0.01% 1719
2024
Q4 		$10.6M Buy
+256,612
New +$10.7M ﹤0.01% 1801

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's MIRM Position: Q2 2026 in Review

Raymond James Financial increased its Mirum Pharmaceuticals (MIRM) stake by 2.3% in Q2 2026, buying an estimated $516K and bringing the position to 233,311 shares worth $27.3M. The position accounts for 0.01% of the portfolio, ranked #1341.

Raymond James Financial first reported a position in MIRM in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Raymond James Financial held 233,311 shares of Mirum Pharmaceuticals worth $27.3M as of Q2 2026.
  • Raymond James Financial bought 5,137 Mirum Pharmaceuticals shares in Q2 2026, an estimated $516K.
  • Mirum Pharmaceuticals made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1341 holding.
  • Raymond James Financial first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.